take a guess ?, page-7

"Anybody willing to make a guesstimate on what effect the FDA approval for DNDN will have on the SP for PRR in the short term, if or when it's approved?"

Given the time frame for US FDA approval for Prima and the uneventful response to ODS designation with the EMEA I'd say we may need to temper our enthusiasm a little to avoid possible disappointment. After all the recent press coverage on Dendreon's FDA application, the market is already anticipating a positive outcome. It will be interesting to see what DNDN's share price will be post announcement. Will it be a case of buy on rumour sell on fact? You'd expect a surge on the days after confirmation, and it's during this period, before the market settles again, that Prima may have a run. Considering the differing stages of the two company's development, l think we will have a modest, rather than earth shattering response. Fast forward a couple of years however, and we'll have been well rewarded for the wait.